Disclosures for "Biofluid Activity and Levels of the Angiotensin-converting Enzyme Are Surrogates for Diverse Cerebrospinal Fluid Amyloid-beta Effects in Dementia with Lewy Bodies and Alzheimer’s Dementia"
-
Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gerson Lehrman Group. Dr. De Oliveira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum Partners. Dr. De Oliveira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lionbridge. Dr. De Oliveira has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
-
Marjorie Miraldo has nothing to disclose.
-
Eduardo Castro-Neto has nothing to disclose.
-
Sandro Almeida has received research support from CNPq.
-
Sandro Luiz de Andra Matas has nothing to disclose.
-
Paulo Bertolucci has received personal compensation for serving as an employee of Roche. Paulo Bertolucci has received personal compensation for serving as an employee of Quintiles. Paulo Bertolucci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Paulo Bertolucci has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sandoz. Paulo Bertolucci has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Danone. The institution of Paulo Bertolucci has received research support from FAPESP.
-
Maria Naffah-Mazzacoratti has nothing to disclose.